2464
We describe a patient with acute myeloblastic leukemia (AML) who developed nephrotic syndrome after receiving several courses of chemotherapy, including macrophage-colony-stimulating factor (M-CSF).
 a patient with acute myeloblastic leukemia (AML): Subject; nephrotic syndrome: Effect; several courses of chemotherapy, including macrophage-colony-stimulating factor (M-CSF): Treatment; acute myeloblastic leukemia: Treatment.Disorder; macrophage-colony-stimulating factor: Treatment.Drug; chemotherapy: Treatment.Route
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a patient with acute myeloblastic leukemia (AML): Subject; nephrotic syndrome: Effect; several courses of chemotherapy, including macrophage-colony-stimulating factor (M-CSF): Treatment; acute myeloblastic leukemia: Treatment.Disorder; macrophage-colony-stimulating factor: Treatment.Drug; chemotherapy: Treatment.Route